Passive immunotherapy using approved vaccines combined with lockdown, as essential parts of the community medicine and public health to survive and even beat COVID: A viewpoint commentary
Main Article Content
Downloads
Article Details
Copyright (c) 2021 Seghatchian J.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Seghatchian J (2020) An introductory commentary on the use of artificial intelligence, machine learning and TQM, as novel computational tools in big data patterns or procedural analysis, in transfusion medicine. Transfus Apher Sci 59: 102985. Link: https://pubmed.ncbi.nlm.nih.gov/33158743/
D'Alessandro A (2020) Benford’s law and metabolomics: a tale of numbers and blood. Transfus Apher Sci 59: 103019. Link: https://bit.ly/34vCCC6
Seghatchian J (2021) New generation of vaccines and convalescent plasma therapy for the management of CoV-2, in the global pandemic. Transfus Apher Sci 60: 103061. Link: https://bit.ly/3i2S8xd
Seghatchian J (2021) Editorial. Facts and challenges on global deployment of vaccines for the immunotherapy of the evolving SARS Cov-2 variants: What a new year, with a fast spreading South African and the most fearful Brazilian variants, as the unwanted gifts, imposing enormous crises to surmount. Link: https://bit.ly/3uw6OHS
Seghatchian J, Acker JP, Putter JS (2020) Update on newer approaches to prevent or treat COVID-19 infection: what we all need the most right now. Transfus Apher Sci 59: 102933. Link: https://bit.ly/3yMl0Qs
Seghatchian J, Lanza F (2020) Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike. Transfus Apher Sci 59: 102794. Link: https://bit.ly/3vB9NQH
Lanza F, Agostini V, Monaco F, Passamonti F, Seghatchian J (2021) Therapeutic use of convalescent plasma in covid-19 infected patients with concomitant hematological disorders. Clinical Hematology International Link: https://bit.ly/3c4O0sO
Putter JS, Seghatchian J (2020) An update on COVID-19 infection control measures, plasma-based therapeutics, corticosteroid pharmacotherapy and vaccine research. Transfus Apher Sci 59: 102934. Link: https://bit.ly/3vK823X
Amiral J, Vissac AM, Seghatchian J (2020) Covid-19, induced activation of hemostasis, and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients? Transfus Apher Sci 59: 102804. Link: https://bit.ly/2RNrZbk
Alessandro D, Tiffany A, Dzieciatkowaska M, Hill RC, Richado F, et al. (2020) Serum proteomics in COVID-19 patients: altered coagulation and complement status as a function of IL-6 level. J Proteome Res 19: 4417-4427. Link: https://bit.ly/2Tvev4x
Mykhailova O, Seghatchain J, Acker J (2020) Assessment of extracellular vesicles using IFC for application in transfusion medicine. Transfus Apher Sci 59: 102942. Link: https://bit.ly/3c2aGKa
Picchianti Diamanti A, Rosado MM, Pioli C, Sesti G, Laganà B (2020) Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern: The fragile balance between infections and autoimmunity. Int J Mol Sci 21: 3330. Link: https://bit.ly/3i8Ts1A
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, et al. (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395: 1417-1418. Link: https://bit.ly/3fykY7k
Connors JM, Levy JH (2020) Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost 18: 1559-1561. Link: https://bit.ly/3ieQau7
Chen G, Zhou Y, Ma J, Xia P, Qin Y, et al. (2020) Is there a role for blood purification therapies targeting cytokine storm syndrome in critically severe COVID-19 patients? Renal Failure 42: 483-488. Link: https://bit.ly/3yLUp5U
Smit Sibinga CT, Abdella YE, Seghatchian J (2020) Poor economics - Transforming challenges in transfusion medicine and science into opportunities. Transfus Apher Sci 59: 102752. Link: https://bit.ly/3uvuDQd